CPHI China 2025 Overview
-
230,000+
EXHIBITION AREA -
100,000+
VISITS -
3,500+
EXHIBITORS
Impressions of the Event
- Natural Extracts
- Bio Pharma
- Pharma Excipients
- Contract Services
- Pharma Ingredients
- Finished Dosage
-
Meet the suppliers of natural extracts and the latest pharmaceutical solutions available on the market. Including influential and active businesses involved in traditional Chinese medicine. -
Immerse yourself in the future of medicine by engaging with providers of Biologics and New Therapies. From cutting-edge Bioprocessing and Manufacturing solutions to innovative Biotechnology and R&D services, this zone is a hotspot for the latest advancements in the biopharmaceutical sector. -
Connect with the essential excipient experts you need to complete your drug delivery system. Whether you need a licencing specialist or a finished dosage manufacturer to make your product a reality. -
Get the assistance you need from a wide range of contract servicing businesses from across the supply chain. From getting help with outsourcing manufacturing to sourcing and product research. -
Explore a diverse array of API and ingredient distributors, along with finished dosage manufacturers seeking the finest product ingredients. This zone is a hub for those engaged in research and development as well as procurement within the pharmaceutical industry. -
Find the delivery solutions you need to make sure your patients get the treatments they need to improve their health. Find suppliers specialising in licensing, end product distribution and end user agents to get your products on the market.
ECHEMI x CPHI CHINA
Products Required
-
Time
June 25thAddress
VIP Lounge -
Schedule
-
Country
Products Required
-
Indonesia
Talc, Thyme, Calcium Lactate
-
Pakistan
Azithromycin Dihydrate USP 43, Ceftriaxone Sodium Sterile, Vitamin D3 40 MIU, Metronidazole, Metronidazole Benzoate, Cefadroxil, Cephradine Compacted, Mannitol
-
Indonesia
Propelene Glycol, polyetheline, Sorbitol, Sacharine, Sucrose
-
Indonesia
Mint Powder, Peppermint Oil, Red Ginger Powder, Nicotinamide Mononucleotide, Atorvastatin, Dexamethasone, Chlorhexidine, Methylprednisolone
-
Indonesia
Menthol, L-Menthol, Vanillin, Maltol
-
Pakistan
Ticagrelor IH/BP/EP, Febuxostat, Rosuvastatin USP, Pregabalin BP/USP, Azilsartan K Medoximil IH, Itraconazole Pellets 22%, Dexlansoprazole Pellets 22.5%, Tamsulosin Pellets 0.2% USP, Orlistat Pellets 50%, Diluted Nitroglycerine 2%, Isosorbide Mono Nitrate 70%, Ondansetron HCl Dihydrate USP BP/USP, Oxcarbazepine BP/USP, Metformin BP/USP, Nebivolol BP/USP, Levetiracetam, Terbinafine, Ferrous Fumarate, Olanzapine, Famotidine, Sumatriptan Succinate, Montelukast Sodium, Ferrous Gluconate
-
India
Vitamin K2 Mk7, Chondroitin Sulphate Sodium, Green Coffee Extract, Macca Extract, Saw Palmito Extract, Epimedium Extract, Ginkgo Biloba Leaf Extract, Green Tea Extract, Pumpkin Seed Extract, Horse Chest Nut Extract, L-Glutathione, Co-Enzyme Q10, Calcitriol, L-Arginine, L-Isoleucine, Melatonin, Kojic Acid, DHA, Lutein, Resveratrol, Astaxanthin, Tongat Ali Extract, Ginseng (Korean) Extract, African Mango Seed Extract, Garcinia Cambogia Extract, Fucoxanthin
-
South Korea
Sodium Polyacrylate, Squalane, Olaflur, Vitamin E Acetate, Salicylic acid, Octyldodecanol, Ammonium Lactate, Vitamin E TPGS
-
Malaysia
Eprinomectin, Pentobarbital, Yohimbine, Imidocarb, Coumaphos, Diminazene
-
Singapore
Acetone, Acetates, Ethanol, Methanol, Butanol, Propanol, Isopropyl Alcohol, Ethylene Glycol, N-Methyl-2-Pyrrolidone, Tetrahydrofuran , Dimethyl Sulfoxide, N,N-Dimethylacetamide, Diisopropyl Ether
-
Indonesia
Paracetamol, Ammonium Chloride, Ibuprofen, Potassium Chloride, Valacyclovir, Acyclovir, Pyrantel Pamoate, Rivaroxaban, Pectin
-
UK
Bempedoic acid, Clopidogrel, Exemestane, Iron (III) chloride hexahydrate, maltodextrin, Sapropterin Hydrochloride, triptorelin acetate microsphere, vitamin D3 (API), vitamin K1 (API), vonoprazan fumarat
-
Country
CONFERENCES & DISCUSSIONS
Defining What's Next in Pharma
CPHI China Pharma Awards 2025
Top Ten Awards
Unique Live Experiences
CPHI CHINA 2025 CAME TO A SUCCESSFUL CONCLUSION!